Literature DB >> 9207510

Arterial versus portal venous helical CT for revealing pancreatic adenocarcinoma: conspicuity of tumor and critical vascular anatomy.

O Graf1, G W Boland, A L Warshaw, C Fernandez-del-Castillo, P F Hahn, P R Mueller.   

Abstract

OBJECTIVE: The purpose of this study was to determine the conspicuity of pancreatic adenocarcinoma and surrounding critical pancreatic vascular structures on helical CT scans obtained during the arterial and portal venous phases of enhancement. SUBJECTS AND METHODS: Forty patients with pancreatic adenocarcinomas under-went dual-phase helical CT (3-mm collimation; l-mm overlapping reconstructions; 160 ml contrast medium injected at 4 ml/sec; scan delay: 18 sec for arterial phase, 60 sec for portal venous phase). Tissue enhancement and differences in tumor-to-pancreas contrast were compared. Quantitative evaluation was also done for the aorta, the superior mesenteric artery and vein, and the splenic and portal veins.
RESULTS: Tumor conspicuity was significantly greater in the portal venous phase, when the tumor-to-pancreas contrast difference was 54 +/- 31 H, than in the arterial phase, when the difference was 31 +/- 29 H. Enhancement values of critical pancreatic venous structures were significantly greater in the portal venous phase than in the arterial phase.
CONCLUSION: Arterial-phase helical CT in patients with pancreatic adenocarcinoma is of limited benefit: lesion conspicuity is suboptimal and depiction of venous anatomy is inferior to the depiction possible with venous-phase helical CT.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9207510     DOI: 10.2214/ajr.169.1.9207510

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  15 in total

Review 1.  Multidetector CT and three-dimensional imaging of the pancreas: state of the art.

Authors:  Karen M Horton
Journal:  J Gastrointest Surg       Date:  2002 Mar-Apr       Impact factor: 3.452

Review 2.  Clinical significance of vascular assessment by contrast-enhanced harmonic ultrasonography of pancreatic carcinomas.

Authors:  Masayuki Kitano
Journal:  J Gastroenterol       Date:  2005-06       Impact factor: 7.527

Review 3.  Advances in imaging for pancreatic disease.

Authors:  Chiara Del Frate; Romeo Zanardi; Koenraad Mortele; Pablo R Ros
Journal:  Curr Gastroenterol Rep       Date:  2002-04

4.  Sixty-four MDCT achieves higher contrast in pancreas with optimization of scan time delay.

Authors:  Tina Stuber; Hans-Jürgen Brambs; Wolfgang Freund; Markus S Juchems
Journal:  World J Radiol       Date:  2012-07-28

Review 5.  Pancreatic adenocarcinoma.

Authors:  Wolfgang Schima; Ahmed Ba-Ssalamah; Claus Kölblinger; Christiane Kulinna-Cosentini; Andreas Puespoek; Peter Götzinger
Journal:  Eur Radiol       Date:  2006-10-05       Impact factor: 5.315

Review 6.  Vascular invasion in pancreatic cancer: Imaging modalities, preoperative diagnosis and surgical management.

Authors:  Nicolas C Buchs; Michael Chilcott; Pierre-Alexandre Poletti; Leo H Buhler; Philippe Morel
Journal:  World J Gastroenterol       Date:  2010-02-21       Impact factor: 5.742

7.  For biliary dilatation, a negative endosonography needs additional image studies in weight loss suggesting malignancy.

Authors:  Chien-Hua Chen; Chi-Chieh Yang; Yung-Hsiang Yeh
Journal:  Dig Dis Sci       Date:  2013-04-02       Impact factor: 3.199

Review 8.  [Pancreas. Part I: congenital changes, acute and chronic pancreatitis].

Authors:  W Schima; A Ba-Ssalamah; C Plank; C Kulinna-Cosentini; A Püspök
Journal:  Radiologe       Date:  2006-04       Impact factor: 0.635

9.  [Pancreas. Congenital changes, acute and chronic pancreatitis].

Authors:  W Schima; A Ba-Ssalamah; C Plank; C Kulinna-Cosentini; A Püspök
Journal:  Radiologe       Date:  2007-05       Impact factor: 0.635

10.  Predicting resectability of periampullary cancer with three-dimensional computed tomography.

Authors:  Michael G House; Charles J Yeo; John L Cameron; Kurt A Campbell; Richard D Schulick; Steven D Leach; Ralph H Hruban; Karen M Horton; Elliot K Fishman; Keith D Lillemoe
Journal:  J Gastrointest Surg       Date:  2004 Mar-Apr       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.